28-07-2026 00:54 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Share Holdings
Aurobindo Pharma Ltd.
 
BSE Code 524804
ISIN Demat INE406A01037
Book Value 394.82
NSE Code AUROPHARMA
Dividend Yield % 0.26
Market Cap 891145.28
P/E 36.90
EPS 41.97
Face Value 1  
Description ( As On June 2026 )No. of ShareHoldersNo. of Shares% of SharesDemat
Promoter          
  Indian Promoter  13  280832385  48.81  280832385  
  Foreign Promoter  1  17690341  3.07  17690341  
  Total Promoter  14  298522726  51.88  298522726  
          
Non Promoter          
 Institutions          
  Mutual Funds / UTI  42  96131215  16.71  96131215  
  FI/Bank/Insurance  25  28711325  4.99  28711325  
  Govt          
  FII          
  Other  710  113803964  19.78  113803964  
  Total Institutions  777  238646504  41.48  238646504  
 Non-Institution          
  Bodies Corporate  1820  2847086  0.49  2845976  
  Individuals          
  NRIs/OCBs  8173  2161183  0.38  2161183  
  Others  228289  33200396  5.77  32626996  
  Total Non-Institution  238282  38208665  6.64  37634155  
Total Non Promoter  239059  276855169  48.12  276280659  
          
  Depository Receipts          
          
Grand Total  239073  575377895  100  574803385  
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.